February 26th, 2013
Mixed Results for Spironolactone in Heart Failure with Preserved Ejection Fraction
Larry Husten, PHD
Although the mineralocorticoid receptor antagonists spironolactone and eplerenone have been shown to be beneficial in patients with heart failure (HF) with reduced ejection fraction (EF), their role in HF patients with preserved EF has not been tested until now. Now the results of the Aldo-DHF study (Aldosterone Receptor Blockade in Diastolic Heart Failure), published in […]
NEJM Journal Watch — Recent Cardiology Articles- 10-Year Mortality in Patients Undergoing PCI for First-Time ST-Segment Elevation Myocardial Infarction
- Possible Connection Between Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy
- Does Knowledge of Asymptomatic Coronary Ischemia Improve Outcomes After Major Vascular Surgery?
- Effect of Telecardiology After Hospital Discharge for Acute Coronary Syndromes
- Intensive BP Reduction for Preventing Major Adverse Cardiovascular Events